The latest price target for Nuvalent (NASDAQ:NUVL) was reported by UBS on March 14, 2025. The analyst firm set a price target for $100.00 expecting NUVL to rise to within 12 months (a possible 39.59% upside). 16 analyst firms have reported ratings in the last year.

The latest analyst rating for Nuvalent (NASDAQ:NUVL) was provided by UBS, and Nuvalent upgraded their buy rating.

The last upgrade for Nuvalent Inc happened on March 14, 2025 when UBS raised their price target to $100. UBS previously had a neutral for Nuvalent Inc.

There is no last downgrade for Nuvalent.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nuvalent, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nuvalent was filed on March 14, 2025 so you should expect the next rating to be made available sometime around March 14, 2026.

While ratings are subjective and will change, the latest Nuvalent (NUVL) rating was a upgraded with a price target of $100.00 to $100.00. The current price Nuvalent (NUVL) is trading at is $71.64, which is out of the analyst’s predicted range.